Tissue Damage in the Canine Normal Esophagus by Photoactivation with Talaporfin Sodium (Laserphyrin): A Preclinical Study
Open Access
- 13 June 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (6), e38308
- https://doi.org/10.1371/journal.pone.0038308
Abstract
Treatment failure at the primary site after chemoradiotherapy is a major problem in achieving a complete response. Photodynamic therapy (PDT) with porfimer sodium (Photofrin®) has some problems such as the requirement for shielding from light for several weeks and a high incidence of skin phototoxicity. PDT with talaporfin sodium (Laserphyrin) is less toxic and is expected to have a better effect compared with Photofrin PDT. However, Laserphyrin PDT is not approved for use in the esophagus. In this preclinical study, we investigated tissue damage of the canine normal esophagus caused by photoactivation with Laserphyrin. Diode laser irradiation was performed at 60 min after administration. An area 5 cm oral to the esophagogastric junction was irradiated at 25 J/cm2, 50 J/cm2, and 100 J/cm2 using a three-step escalation. The irradiated areas were evaluated endoscopically on postirradiation days 1 and 7, and were subjected to histological examination after autopsy. The areas injured by photoactivation were 52 mm2, 498 mm2, and 831 mm2 after irradiation at 25 J/cm2, 50 J/cm2, and 100 J/cm2, respectively. Tissue injury was observed in the muscle layer or even deeper at any irradiation level and became more severe as the irradiation dose increased. At 100 J/cm2 both inflammatory changes and necrosis were seen histologically in extra-adventitial tissue. To minimize injury of the normal esophagus by photoactivation with Laserphyrin, diode laser irradiation at 25 J/cm2 appears to be safe. For human application, it would be desirable to investigate the optimal laser dose starting from this level.Keywords
This publication has 17 references indexed in Scilit:
- Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinomaEndoscopy, 2011
- Outcome of Photodynamic Therapy Using NPe6 for Bronchogenic Carcinomas in Central Airways >1.0 cm in DiameterClinical Cancer Research, 2010
- Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopyLung Cancer, 2007
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancerThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Photodynamic Therapy of Early Squamous Cell Carcinomas of the Esophagus: A Review of 31 CasesEndoscopy, 1998
- Photodynamic Therapy in Oncology: Mechanisms and Clinical UseJNCI Journal of the National Cancer Institute, 1993
- Photodynamic therapyEuropean Journal of Cancer, 1992
- Cutaneous phototoxic occurrences in patients receiving Photofrin®Lasers in Surgery and Medicine, 1990
- LOCALIZATION OF MONO‐L‐ASPARTYL CHLORIN e6 (NPe6) IN MOUSE TISSUESPhotochemistry and Photobiology, 1987